Clinical Trial Update: Study Of FOLFIRI Chemotherapy With Or Without Sunitinib In Patients With Metastatic Colorectal Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating FOLFIRI chemotherapy with or without Sunitinib in metastatic colorectal cancer; results were posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Irinotecan (Irinotecan)
• Sunitinib (sunitinib)

Snippet

Sponsor: Pfizer | Conditions: Metastatic Colorectal Cancer | Phase 3 | Status: COMPLETED | Results posted: 2011-06-03